• Study of BI-1206, Rituximab, and Acalabrutinib for Patients with Relapsed or Refractory Indolent B-Cell Non-Hodgkin Lymphoma

    Not recruiting

    1 1 1 1
    Germany Spain
  • Study of Ceralasertib for Patients with Advanced Cancer with Molecular Changes

    Not recruiting

    2 1 1
    Investigated diseases:
    Investigated drugs:
    France
  • Study of PM14 and Irinotecan for Patients with Advanced Solid Tumors

    Not recruiting

    2 1 1 1
    Investigated diseases:
    Investigated drugs:
    Spain
  • Study on the Effectiveness and Safety of 0.1% Mometasone Furoate Emulsion and Ecural Cream for Adults with Plaque Psoriasis

    Not recruiting

    3 1 1
    Investigated diseases:
    Poland
  • Study on Automatic Oxygen Control for Extremely Preterm Infants Using Oxygen PH.EUR.

    Not recruiting

    3 1 1 1
    Investigated drugs:
    Germany
  • Study on the Safety and Effectiveness of IMGN151 for Women with Recurrent Endometrial and Ovarian Cancer

    Not recruiting

    2 1 1 1
    Belgium France Germany Ireland Italy The Netherlands +1
  • Study of Florastamin (18F) PET/CT Imaging for Detection of Significant Prostate Cancer in Patients with Elevated PSA Levels and Unclear MRI Results

    Not recruiting

    3 1 1
    Investigated diseases:
    Austria
  • Study of Nivolumab for Patients with High-Risk Stage II Melanoma After Surgery

    Not recruiting

    3 1 1 1
    Investigated diseases:
    Investigated drugs:
    Germany
  • Study on Voxelotor for Reducing Hemolysis in Patients with Sickle Cell Disease

    Not recruiting

    2 1 1 1
    Investigated diseases:
    Investigated drugs:
    France
  • Study on the Safety and Effectiveness of IMM-101 with Radiotherapy for Patients with Limited Metastatic Pancreatic Cancer

    Not recruiting

    1 1 1
    Investigated diseases:
    The Netherlands

powered by